Your prediction
Syndax Pharmaceuticals Inc Stock
We can see a decrease in the price for Syndax Pharmaceuticals Inc. Compared to yesterday it has lost -€0.200 (-1.150%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Syndax Pharmaceuticals Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Syndax Pharmaceuticals Inc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Syndax Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | -1.150% | -0.571% | 20.000% | 34.884% | 41.463% | -23.009% | - |
| Pacira Pharmaceuticals | 1.900% | 4.902% | 4.902% | 14.439% | 15.676% | -49.528% | -53.275% |
| Rockwell Medical Inc. | -0.990% | -5.729% | -2.742% | -59.451% | -60.417% | -14.194% | -92.157% |
| Twist Bioscience Corp | -2.080% | -5.009% | -4.111% | -41.759% | -42.357% | 8.611% | -77.470% |
News
Syndax (SNDX) Q2 Revenue Jumps 986%
Syndax Pharmaceuticals (NASDAQ:SNDX), a biopharmaceutical company specializing in oncology therapeutics, reported its second-quarter 2025 earnings on August 4, 2025. The most notable news was its
